EuroBio Report : A Critical Look at Drug Regulations

PharmaManufacturing.com

Industry experts provide a critical analysis of regulation policy in both the U.S. and Europe at the EuroBio 2007 Show in Lille, France.

Christopher-Paul Milne of the Tufts Center for the Study of Drug Development analyzes the 'Impact of Regulation on the Time, Cost and Success Rate for the R&D of Biopharmaceuticals' at the 2007 EuroBio Show. Chris Strutt of GSK Biologicals, in 'A Regulatory Environment to Support Innovation' discusses the changing policy environment in Europe for the discovery, development and delivery of pharmaceuticals.